SpaceX, Elon Musk’s spacecraft and satellite communications company, is preparing to go public after reportedly filing ...
April 8 (Reuters) - OpenAI plans to reserve ⁠a ⁠portion of its shares ⁠from an initial public offering for individual ...
Silicon Valley is known for its lavish perks to attract top talent, such as nap pods and free slippers in its “no shoes” ...
AUSTIN, Texas--(BUSINESS WIRE)--Swarmer, Inc (“Swarmer”), a drone autonomy software company supporting operations in Ukraine, today announced the pricing of its initial public offering (the “Offering” ...
Swarmer, Inc (“Swarmer”), a drone autonomy software company supporting operations in Ukraine, today announced the pricing of its initial public offering (the “Offering”) of 3,000,000 shares of its ...
Las Vegas, Nevada, March 10, 2026 (GLOBE NEWSWIRE) -- SUMA Acquisition Corporation (NASDAQ: SUMAU) (the “Company”) today announced the pricing of its initial public offering of 15,000,000 units at a ...
TORONTO — MDA Space Ltd. says it is launching an initial public offering in the U.S. with an application to list its common shares on the New York Stock Exchange. The company says a total of US$300 ...
Connecting the dots: For the first time in more than two decades years, computer science enrollment across the University of California system has fallen, a drop some educators see as a reflection of ...
This content has been selected, created and edited by the Finextra editorial team based upon its relevance and interest to our community. PayPay’s IPO was expected in December, but was delayed due to ...
ALISO VIEJO, Calif., Feb. 05, 2026 (GLOBE NEWSWIRE) -- SpyGlass Pharma, Inc. (Nasdaq: SGP) (“SpyGlass Pharma”), a late-stage biopharmaceutical company, today announced the pricing of its initial ...
Veradermics, Incorporated (“Veradermics”), (NYSE: MANE) a dermatologist-founded, late clinical-stage biopharmaceutical company focused on developing innovative therapeutics for common aesthetic and ...
NEW HAVEN, Conn.--(BUSINESS WIRE)--Veradermics, Incorporated (“Veradermics”), (NYSE: MANE) a dermatologist-founded, late clinical-stage biopharmaceutical company focused on developing innovative ...